Characterization of Drug Release from Mesoporous SiO2-Based Membranes with Variable Pore Structure and Geometry

Abstract

Transdermal drug delivery systems (TDDSs) play important roles in therapy due to distinct advantages over other forms and types of drug application. While common TDDS patches mainly consist of polymeric matrices so far, inorganic carriers show numerous advantages such as high mechanical stability, possible re-use and re-loading of drugs, and a broad chemical compatibility with therapeutically relevant compounds and chemical enhancers. Mesoporous glasses can be prepared in different monolithic shapes, and offer a particularly wide range of possible pore volumes, pore diameters, and specific surface areas. Further, they show high loading capacities and favorable physical, technical, and biological properties. Here, we explored for the first time monolithic SiO2-based carriers as sustained release systems of therapeutic drugs. In an ideally stirred vessel as model system, we systematically analyzed the influence of pore diameter, pore volume, and the dimensions of glass monoliths on the loading and sustained release of different drugs, including anastrozole, xylazine, imiquimod, levetiracetam, and flunixin. Through multilinear regression, we calculated the influence of different parameters on drug loading and diffusion coefficients. The systematic variation of the mesoporous glass properties revealed pore volumes and drug loading concentrations, but not pore diameter or pore surface area as important parameters of drug loading and release kinetics. Other relevant effectors include the occurrence of lateral diffusion within the carrier and drug-specific properties such as adsorption. The structure–property relationships derived from our data will allow further fine-tuning of the systems according to their desired properties as TDDS, thus guiding towards optimal systems for their use in transdermal drug applications.

Recent Advances in Mesoporous Silica Nanoparticle-Mediated Drug Delivery for Breast Cancer Treatment

“…Most surprisingly, the analysis revealed a greater drug release for large PVs (0.17–0.27 cm 3 ·g −1 ) within 60 min, whereas for lower PVs (0.13 cm 3 ·g −1 ), the maximum release extent was attained in 150 min. Enhanced mesoporous sensitivity with smaller pore diameters and 0.13–1.12 cm 3 ·g −1 PVs implied a direct correlation of drug release on PVs and predicted a significant linear correlation between the diffusion coefficient and PV [ 129 ]. This study analyzed the transdermal release efficacy of the drugs, and since the skin environment exhibits significantly distinct permeability than tissues within the body, these results might not be compatible for drug delivery to solid tumors.…”